| Sorafenib in patients with metastatic renal cell carcinoma refractory to ... - UroToday |
|
|
UroTodayBevacizumab and sunitinib are standard initial therapy in metastatic renal cell carcinoma (mRCC). Despite common use, the safety and activity of sorafenib ... read more |